Comparison between CWD IPO and Nidan Laboratories IPO.
CWD IPO is a SME Fixed Price IPO proposed to list at BSE SME while Nidan Laboratories IPO is a SME Fixed Price proposed to list at NSE SME.
| CWD IPO | Nidan Laboratories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | First Overseas Capital Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of CWD IPO is up to ₹17.11 Cr whereas the issue size of the Nidan Laboratories IPO is up to ₹47.50 Cr. The final issue price of CWD IPO is ₹180.00 per share and of Nidan Laboratories IPO is ₹125.00 per share.
| CWD IPO | Nidan Laboratories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹180.00 per share | ₹125.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 800 shares | 1000 shares |
| Fresh Issue Size | 8,00,400 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹14.41 Cr | up to ₹47.50 Cr |
| OFS Issue Size | 1,50,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹2.70 Cr | up to ₹0.00 Cr |
| Issue Size Total | 9,50,400 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹17.11 Cr | up to ₹47.50 Cr |
CWD IPO opens on Sep 30, 2021, while Nidan Laboratories IPO opens on Oct 28, 2021. The closing date of CWD IPO and Nidan Laboratories IPO is Oct 05, 2021, and Nov 02, 2021, respectively.
| CWD IPO | Nidan Laboratories IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 30, 2021 | Oct 28, 2021 |
| Issue Close | Oct 05, 2021 | Nov 02, 2021 |
| Basis Of Allotment (Tentative) | Oct 08, 2021 | Nov 09, 2021 |
| Initiation of Refunds (Tentative) | Oct 11, 2021 | Nov 10, 2021 |
| Credit of Share (Tentative) | Oct 12, 2021 | Nov 11, 2021 |
| Listing date (Tentative) | Oct 13, 2021 | Nov 12, 2021 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
CWD IPO P/E ratio is , as compared to Nidan Laboratories IPO P/E ratio of .
| CWD IPO | Nidan Laboratories IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 99.99 | ||||
| Promoter Shareholding (Post-Issue) | 72.29 | 71.22 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹65.01 Cr. | ₹173.75 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the CWD IPO Retail Individual Investors (RII) are offered 4,75,200 shares while in Nidan Laboratories IPO retail investors are offered 4,75,200 shares. Qualified Institutional Buyers (QIB) are offered in CWD IPO and in Nidan Laboratories IPO.
| CWD IPO | Nidan Laboratories IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 50,400 shares | 2,00,000 shares |
| QIB | ||
| NII | 4,75,200 shares | 19,00,000 shares |
| RII | 4,75,200 shares | 19,00,000 shares |
| Employee | ||
| Others | ||
| Total | 9,50,400 shares | 38,00,000 shares |
CWD IPO subscribed 1.31x in total, whereas Nidan Laboratories IPO subscribed 1.80x.
| CWD IPO | Nidan Laboratories IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.91x | 0.15x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.71x | 3.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.31x | 1.80x |
